The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III study of NUC-1031 + cisplatin versus gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121).
 
Jennifer J. Knox
Honoraria - Novartis; Roche Canada
Consulting or Advisory Role - AstraZeneca/MedImmune; Lilly; Merck
Research Funding - AstraZeneca; Ipsen; Merck
Expert Testimony - AstraZeneca
 
Mairead Geraldine McNamara
Honoraria - Novartis
Consulting or Advisory Role - Incyte; Ipsen; Shire; Sirtex Medical
Speakers' Bureau - Nucana
Research Funding - Ipsen; Nucana; SERVIER
Travel, Accommodations, Expenses - Bayer; Novartis
 
Lipika Goyal
Consulting or Advisory Role - Agios; Alentis Therapeutics; AstraZeneca; Debiopharm Group; Exelixis; Genentech; H3 Biomedicine; Incyte; Klus Pharma; QED Therapeutics; Sirtex Medical; Taiho Pharmaceutical
(OPTIONAL) Uncompensated Relationships - Agios; Debiopharm Group; Merck; Taiho Pharmaceutical
 
David Cosgrove
Employment - Biocompatibles; Compass Oncology
Leadership - US Oncology
Consulting or Advisory Role - Biocompatibles
Speakers' Bureau - Biocompatibles
Travel, Accommodations, Expenses - US Oncology
 
Christoph Springfeld
Consulting or Advisory Role - Bayer; Celgene; Eisai; MSD; Roche; SERVIER
Travel, Accommodations, Expenses - Celgene; Servier
 
Katrin Marie Sjoquist
Honoraria - AMGEN; BMS; Ipsen; Merck; SERVIER
Consulting or Advisory Role - Competitive Drug Development International
Research Funding - Bayer (Inst)
 
Joon Oh Park
Consulting or Advisory Role - AstraZeneca; Celgene; GI Innovation; Merck Serono; SERVIER
Speakers' Bureau - Celgene
Research Funding - Celgene; medpacto
 
Helena Verdaguer
No Relationships to Disclose
 
Chiara Braconi
Honoraria - Bayer (I); Lilly (I); Menarini Silicon Biosystems (I); Merck Serono (I); Pfizer (I)
Travel, Accommodations, Expenses - Bayer (I); Lilly (I); Menarini Silicon Biosystems (I); Merck Serono (I); Pfizer (I)
 
Paul J. Ross
Honoraria - Eisai; Pierre Fabre; Roche; SERVIER; Shire; Sirtex Medical
Consulting or Advisory Role - Eisai; Pierre Fabre; Roche; SERVIER; Shire; Sirtex Medical
Speakers' Bureau - Amgen; Merck; Roche; SERVIER; SERVIER
Research Funding - Bayer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Bayer; Roche; SERVIER
 
Do-Youn Oh
Consulting or Advisory Role - ASLAN Pharmaceuticals; AstraZeneca; Basilea; Bayer; BeiGene; Celgene; Genentech/Roche; Halozyme; Merck Serono; Novartis; Taiho Pharmaceutical; Zymeworks
Research Funding - Array BioPharma; AstraZeneca; BeiGene; Lilly; MSD; Novartis; SERVIER
 
Aimery De Gramont
No Relationships to Disclose
 
John Raymond Zalcberg
Stock and Other Ownership Interests - Acceleron Pharma; Aimmune; Alnylam; Amarin Corporation; Biomarin; Concert Pharmaceuticals; Frequency Therapeutics; Gilead Sciences; Global Blood Therapeutics; GW Pharmaceuticals; Madrigal Pharmaceuticals; Moderna Therapeutics; Myovant Sciences; Opthea; Orphazyme; Sangamo Bioscience; Twist Bioscience; UniQure; Vertex; Zogenix
Honoraria - Deciphera; Gilead Sciences; Halozyme; Merck Serono; Specialised Therapeutics; Targovax
Consulting or Advisory Role - Center for Emerging & Neglected Diseases (CEND); Deciphera; Halozyme; Lipotek; Merck Serono; Merck Sharp & Dohme; Specialised Therapeutics; Targovax
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); IQvia (Inst); Medtronic (Inst); Merck Serono (Inst); MSD Oncology (Inst); Mylan (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Deciphera; Merck Serono; Merck Sharp & Dohme; Sanofi
 
Daniel H. Palmer
No Relationships to Disclose
 
Juan W. Valle
Honoraria - Ipsen
Consulting or Advisory Role - Agios; Aptitude Health; AstraZeneca; Baxter; Debiopharm Group; Genoscience Pharma; Hutchison MediPharma; Imaging Equipment Limited; Incyte; Ipsen; Keocyt; Merck; Mundipharma; Novartis; Nucana; PCI Biotech; Pfizer; Pieris Pharmaceuticals; QED Therapeutics; SERVIER; Sirtex Medical; Wren Laboratories; Zymeworks
Speakers' Bureau - Imaging Equipment Limited; Incyte; Ipsen; Mylan; Novartis; Nucana
Travel, Accommodations, Expenses - Lilly; Nucana; Pfizer